News
The Ovation and the Asterisk
Five trials, five cancers, and what the ASCO 2026 plenary really promised patients ASCO 2026’s plenary delivered five real advances across five cancers, and a standing ovation that pulled a hall full of oncologists to their feet. The harder question…
Between Theory and Bedside: What Early Palliative Care in Singapore Reveals About Cancer, Care, and the Limits of Knowledge
On paper, cancer care can be mapped, measured, and modelled. In practice, it is far less contained. For Charis Ng, a trainee health psychologist and PhD student, that gap between theory and lived reality became impossible to ignore during her…
The Right to Be Forgotten: Why Voluntary Measures are Not Enough for Cancer Survivors
On World Cancer Day, Commissioners Várhelyi and Albuquerque reaffirmed the European Commission’s commitment to the right to be forgotten for cancer survivors. Yet their announcement of non-binding guidance to financial institutions in 2026 falls significantly short of what survivors and…
European Cancer Nursing Day 2026: Supporting Life Beyond Cancer
Europe-wide online event highlights survivorship, innovation, education, advocacy, and the future of cancer nursing On 18 May 2026, the European Oncology Nursing Society (EONS) marked European Cancer Nursing Day (ECND26) with an online Europe-wide celebration bringing together cancer nurses under…
Oncologists Urged to Have Open Discussion about CAM Use with Patients
CAM use linked to higher mortality in breast cancer patients A cohort study of women with breast cancer has shown that use of complementary and alternative medicine (CAM) in association with traditional therapies was associated with higher mortality compared with…
The Scientists Who Turned Cancer Prevention into a Vaccine: Dr Douglas Lowy and Dr John Schiller
The 2026 Pezcoller Foundation–AACR International Award for Extraordinary Achievement in Cancer Research has recognised two scientists whose discoveries reshaped one of oncology’s greatest ambitions: preventing cancer before it begins. On 9 May, at the Teatro Sociale in Trento, Italy, Dr…
Cancer is Universal. Meaning is Not!
She nodded when I said cancer. Only later did I understand that she had heard something else. The consultation unfolded with clinical precision. The translation was accurate. From a professional perspective, nothing was missing. And yet everything was. When I…
CancerWorld #116 (June 2026)
We tend to talk about cancer in the language of progress—new therapies, wider prevention, smarter models of care. It is a comforting vocabulary. It is also incomplete. Progress in oncology is never only scientific. It is institutional, social, and deeply…
A Survivor’s Perspective: San Diego’s Rise as a National Cancer Research Hub
How policy, philanthropy, and scientific collaboration are reshaping the cancer research landscape and why early detection can be the difference between life and death. Twenty years ago, I received a diagnosis that changed everything and led me to dedicate the…
A Matter of Timing: Radiotherapy Efficacy Linked to Circadian Regulation
Timing of radiotherapy administration may significantly influence treatment efficacy in breast and prostate cancer. A Spanish study, published in Nature Communications, demonstrates that circadian oscillation of Cryptochrome 1 (CRY1) modulates DNA double-strand break (DSB) repair, making radiotherapy more effective in…